1 Introduction
1.1 What Is This Report About?
1.2 Metabolic Disorders Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Metabolic Disorders Market, South Korea
2.1 Metabolic Disorders Market, South Korea, Revenue ($m), 2024-2036
2.1.1 Cholesterol Tests Market, South Korea, Revenue ($m), by Segment, 2024-2036
2.1.2 Diabetes Assays Market, South Korea, Revenue ($m), by Segment, 2024-2036
2.2 Metabolic Disorders Market, South Korea, Volume (Units), 2024-2036
2.2.1 Cholesterol Tests Market, South Korea, Volume (Units), by Segment, 2024-2036
2.2.2 Diabetes Assays Market, South Korea, Volume (Units), by Segment, 2024-2036
2.3 Metabolic Disorders Market, South Korea, Average Price ($), 2024-2036
2.4 Metabolic Disorders Market, South Korea, Company Share by Revenue ($m), 2025
3 Metabolic Disorders Market Pipeline Products
3.1 Metabolic Disorders Market Pipeline Products
3.2 Metabolic Disorders - Pipeline Products by Stage of Development
3.3 Metabolic Disorders - Pipeline Products by Segment
3.4 Metabolic Disorders - Pipeline Products by Territory
3.5 Metabolic Disorders - Pipeline Products by Regulatory Path
3.6 Metabolic Disorders - Pipeline Products by Estimated Approval Date
4 Overview of Key Companies in South Korea, Metabolic Disorders Market
4.1 Siemens Healthineers AG
4.1.1 Company Overview
4.2 Roche Diagnostics International Ltd
4.2.1 Company Overview
4.3 Beckman Coulter Inc
4.3.1 Company Overview
4.4 Abbott Laboratories
4.4.1 Company Overview
5 Recent Developments
5.1 Product News
5.1.1 Sep 19, 2025: Boditech Med Launches Advanced Diabetes Diagnostics at EASD 2025
6 Appendix
6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Benchmarking
6.2 the Analyst Consulting
6.3 Contact Us
6.4 Disclaimer
List of Tables
Table 1: Metabolic Disorders Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Table 2: Cholesterol Tests Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Table 3: Diabetes Assays Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Table 4: Metabolic Disorders Market, South Korea, Volume (Units), 2024-2036
Table 5: Cholesterol Tests Market, South Korea, Volume (Units), 2024-2036
Table 6: Diabetes Assays Market, South Korea, Volume (Units), 2024-2036
Table 7: Metabolic Disorders Market, South Korea, Average Price ($), 2024-2036
Table 8: Metabolic Disorders Market, South Korea, Company Share by Revenue ($m), USD Constant, 2025
Table 9: Metabolic Disorders Market Pipeline Products
Table 10: Metabolic Disorders - Pipeline Products by Stage of Development
Table 11: Metabolic Disorders Companies - Pipeline Products by Stage of Development
Table 12: Metabolic Disorders - Pipeline Products by Segment
Table 13: Metabolic Disorders - Pipeline Products by Territory
Table 14: Metabolic Disorders - Pipeline Products by Regulatory Path
Table 15: Metabolic Disorders - Pipeline Products by Estimated Approval Date
Table 16: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Metabolic Disorders Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Figure 2: Cholesterol Tests Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Figure 3: Diabetes Assays Market, South Korea, Revenue ($m), USD Constant, 2024-2036
Figure 4: Metabolic Disorders Market, South Korea, Volume (Units), 2024-2036
Figure 5: Cholesterol Tests Market, South Korea, Volume (Units), 2024-2036
Figure 6: Diabetes Assays Market, South Korea, Volume (Units), 2024-2036
Figure 7: Metabolic Disorders Market, South Korea, Company Share (%), 2025
Figure 8: Metabolic Disorders - Pipeline Products by Stage of Development
Figure 9: Metabolic Disorders - Pipeline Products by Segment
Figure 10: Metabolic Disorders - Pipeline Products by Territory
Figure 11: Metabolic Disorders - Pipeline Products by Regulatory Path
Figure 12: Metabolic Disorders - Pipeline Products by Estimated Approval Date